PEPTOLITE CHEWABLE TABLETS

Pays: Israël

Langue: anglais

Source: Ministry of Health

Ingrédients actifs:

BISMUTH SUBSALICYLATE

Disponible depuis:

PERRIGO ISRAEL AGENCIES LTD, ISRAEL

Code ATC:

A02BX05

forme pharmaceutique:

CHEWABLE TABLETS

Composition:

BISMUTH SUBSALICYLATE 262 MG

Mode d'administration:

PER OS

Type d'ordonnance:

Not required

Fabriqué par:

PERRIGO COMPANY, USA

Groupe thérapeutique:

BISMUTH SUBCITRATE

Domaine thérapeutique:

BISMUTH SUBCITRATE

indications thérapeutiques:

For relief of diarrhea, nausea, flatulence, abdominal cramps, upset stomach and indigestion.

Date de l'autorisation:

2013-07-31

Notice patient

PATIENT PACKAGE INSERT
IN ACCORDANCE WITH THE
PHARMACISTS’ REGULATIONS
(PREPARATIONS) - 1986
The medicine is
dispensed without a
doctor’s prescription
PEPTOLITE
CHEWABLE
TABLETS 262 MG
PEPTOLITE
SUSPENSION
262.5 MG/15 ML
Each tablet contains:
Bismuth Subsalicylate 262 mg
Each 15 ml of suspension contains:
Bismuth Subsalicylate 262.5 mg
*Inactive ingredients in the preparation
- see section 6 in the leaflet.
READ THIS PACKAGE INSERT CAREFULLY
IN ITS ENTIRETY BEFORE USING THIS
MEDICINE. This leaflet contains concise
information about the medicine. If you
have further questions refer to your
physician or pharmacist.
The medicine is intended for adults
and children above 12 years of age.
Below the age of 12, you should refer
to your doctor.
The medicine must be used correctly.
Consult the pharmacist if you need
further information. Stop taking the
medicine and contact the physician
if signs of the illness (symptoms)
get worse or do not improve after
two days. Likewise, if the diarrhea
is accompanied by high fever, if you
experience ringing in the ears or loss
of hearing.
1. WHAT IS THE MEDICINE INTENDED
FOR?
The medicine is intended to relieve
cases of diarrhea, nausea, flatulence,
abdominal cramps, upset stomach
and indigestion.
2. BEFORE USING THE MEDICINE:
DO NOT USE THE MEDICINE IF:
• You are sensitive (allergic) to the
active ingredient or to any other
ingredients contained in the
medicine.
• Do not use in children and
adolescents up to 20 years of
age for illnesses accompanied by
fever such as flu and chickenpox
(for fear of Reye’s syndrome).
• The medicine contains salicylate.
Do not use the medicine if you are
allergic to salicylates (including
aspirin) or if you are taking
other preparations that contain
salicylate.
• You have a stomach ulcer,
bleeding, bloody or black stool.
SPECIAL WARNINGS REGARDING USE OF
THE MEDICINE:
• Before starting treatment with
Peptolite tell the doctor if:
you are pregnant or breastfeeding.
you are suffering or have suffered in
the past from impaired function of: